comparison of drug nalbuphine and tramadol used for shivering after spinal anaesthesia

Randomised double blind comparitive study of intravenous nalbuphine and tramadol for post-spinal anaesthesia shivering

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/012125

Enrollment

Registered

2018-02-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: -

Interventions

Intervention1: Nalbuphine: IV Nalbuphine 0.06 mg/kg in 5 ml normal saline. Control Intervention1: Tramadol: IV Tramadol 1mg/kg in 5ml normal saline.

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of ASA physical status I &II 2.Age between 18-50 yrs of age of either sex who have undergone routine general, orthopaedic, or gynaecological and obstetrical surgery under spinal anaesthesia. 3.Post anaesthetic shivering occurring within 10min of admission to recovery room

Exclusion criteria

Exclusion criteria: 1. 50 yr of age 2.Post anaesthetic shivering occurring after 10 min of admission to recovery room 3.Known hyperthyroidism, cardiopulmonary or neuromuscular pathology 4.Patients with contraindication for the use of Nalbuphine and Tramadol will not be included

Design outcomes

Primary

Measure	Time frame
1.To compare the effectiveness of intravenous nalnupine and tramadol for post spinal anaesthesia shivering. Timepoint: 0min,5min,10min,15min,20min,25min,30min	—

Secondary

Measure	Time frame
1.To study the adverse effects if any. 2.To compare any haemodynamic changes Timepoint: 0min,5min,10min,15min,20min,25min,30min	—

Countries

India

Contacts

Public ContactDEEPAK KUMAR NIRALA

Indira Gandhi Institute Of Medical Sciences

dr.khraghwendra@ymail.com9835092798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026